ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
Bioinformatics and AI at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
30 organizations at ASHI 2026 present work in bioinformatics, AI and risk modeling, led by academic, government and non-profit bodies. Between them they bring 91 presentations to the program. Most represented: University of British Columbia, Thermo Fisher Scientific and University of California, San Francisco. As of Oct 25, 2026.
| Organization | ASHI 2026 Attendance |
|---|---|
University of British Columbia Vancouver, BC | |
Public research university with a faculty of medicine affiliated with teaching hospitals in Vancouver and across British Columbia. | Industry Tue Oct 27 12:30pm–1:25pm Redefining Histocompatibility: Faster HLA Typing, Deeper Ab Insights HLA typing, sequencing and genotypingHLA antibodies, crossmatching and eplets Talk Tue Oct 27 2:30pm–2:45pm A Novel Serum Lipid Signature Identifies Antibody-Mediated Rejection Without Biopsy Solid organ transplantationChimerism, cell-free DNA and post-transplant monitoring Session Wed Oct 28 10:30am–12:00pm Plenary 2: Real World Implications of Deploying AI in Transplantation Bioinformatics, AI and risk modeling Talk Wed Oct 28 2:45pm–3:15pm Pre-analytic Considerations and the Analytic Validity of Decentralized Donor-Derived Cell-Free DNA Testing Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Talk Thu Oct 29 10:00am–10:15am Talk Thu Oct 29 1:10pm–1:40pm "Classical" Antibody-Mediated Rejection (ABMR) with Detectable Donor-Specific HLA Antibodies Solid organ transplantationHLA antibodies, crossmatching and eplets Talk Thu Oct 29 2:25pm–2:40pm Impact of Pre-Analytic Sample Stability on Downstream Donor-Derived Cell Free DNA Results Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Session Thu Oct 29 4:15pm–5:45pm Workshop 5: Transplant Balancing Act: Navigating Infection and Rejection in the Era of the Microbiome Solid organ transplantation Session Fri Oct 30 9:30am–10:30am ASHI/CST Joint Session 5: cfDNA Diagnostics Utility in the Era of "Liquid Biopsy". Promises and Challenges in Transplantation Chimerism, cell-free DNA and post-transplant monitoringSolid organ transplantation Session Fri Oct 30 10:30am–12:00pm ASHI/CST Joint Session 6: Desensitization in Solid Organ Transplantation: From immunologic challenge to new opportunities Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Evaluation of Rbceq2 for High Resolution Genotyping of ABO And Other Relevant Blood Group Genes in Transplantation HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling |
Thermo Fisher Scientific Waltham, MA | |
Through its One Lambda line, makes HLA typing and antibody detection assays plus post-transplant monitoring tests for transplant labs and clinicians. | Booth Exhibiting at Booth 311 Mon, Oct 267:00pm–9:00pmTue, Oct 279:15am–10:15amWed, Oct 289:30am–10:30am, 4:15pm–4:45pmThu, Oct 299:30am–10:00am Industry Tue Oct 27 12:30pm–1:25pm Redefining Histocompatibility: Faster HLA Typing, Deeper Ab Insights HLA typing, sequencing and genotypingHLA antibodies, crossmatching and eplets Talk Tue Oct 27 3:00pm–3:15pm Cytoplasmic Tail Polymorphisms are Associated with the Pan-HLA-C Pattern in LABScreen(TM) Assays HLA antibodies, crossmatching and epletsHLA typing, sequencing and genotyping Industry Wed Oct 28 12:40pm–1:35pm Modernizing the HLA Laboratory through Platform Innovation Lab quality, accreditation and operations Poster Automation of LABType HLA Typing using the HLA PRO Liquid Handling Platform Lab quality, accreditation and operationsHLA typing, sequencing and genotyping Poster Experimental Modification of Non-Specific Reactivity Treatment to Reduce Unexpected Reactivity HLA antibodies, crossmatching and epletsLab quality, accreditation and operations Poster Widespread HC-10 Reactivity Across HLA Class I–Expressing Cell Types HLA antibodies, crossmatching and eplets Poster Novel Research Algorithm for Detecting Partial and Complete Loss of Human Leukocyte Antigen Chimerism, cell-free DNA and post-transplant monitoringBioinformatics, AI and risk modeling Poster From Manual to Automated: Performance analysis of the One Lambda™ HybriType™ HLA plus typing Flex Kit using the HLA PRO Lab quality, accreditation and operationsHLA typing, sequencing and genotyping Poster Evaluation of Informative Marker Performance: One Lambda™ Devyser Chimerism Plus vs Standard Assay for Donor-Recipient Analysis on the MiSeq™ i100 Plus Platform Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Poster HLA PRO Automated System Produces Reproducible, High-Quality Data using One Lambda™ HybriType™ HLA Plus Typing Flex Kit Lab quality, accreditation and operationsHLA typing, sequencing and genotyping Poster Magnetic Bead–Based Isolation Enables Kinetic Characterization of HLA-Specific Antibodies by SPR and BLI HLA antibodies, crossmatching and eplets Poster Using HDX-MS to Map the Epitope of Anti-HLA-B*08:01 Antibodies HLA antibodies, crossmatching and eplets Poster HLA PRO: Supporting high-throughput HLA antibody screening workflow Lab quality, accreditation and operationsHLA antibodies, crossmatching and eplets |
University of California, San Francisco San Francisco, CA | |
Public university devoted to health sciences, with schools of medicine, nursing, pharmacy and dentistry and a medical center with organ transplant programs. | Talk Mon Oct 26 3:00pm–3:40pm Engineering an Implantable Bioartificial Kidney: Integrating Device Development and Renal Cell Biology Solid organ transplantation Talk Tue Oct 27 3:00pm–3:15pm Clinical Genome Resource HLA Working Group: HLA Curation in Complex Diseases HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling Talk Wed Oct 28 3:15pm–3:30pm Mapping Immunogenic HLA Eplets Using Monospecific Antibodies in Transplant Patients to Improve Risk Stratification and Access HLA antibodies, crossmatching and eplets Poster Resolving HLA-DPB1 Typing Ambiguity in a Deceased Donor Using Long-Read Nanopore Sequencing HLA typing, sequencing and genotyping Poster Integrating SSHAARP Maps into the Allele Frequencies Net Database Bioinformatics, AI and risk modelingHLA typing, sequencing and genotyping |
Brigham and Women's Hospital Boston, MA | |
Teaching hospital of Harvard Medical School and member of the Mass General Brigham system, with organ and stem cell transplant programs. | Session Mon Oct 26 12:30pm–5:00pm Featured Topic: Organs and Tissues on Demand: Bioengineering and Regenerative Medicine in Transplantation Solid organ transplantation Talk Tue Oct 27 2:30pm–2:45pm A Reusable Novel-Allele Discovery Pipeline Closes ABO Allele-Database Gaps HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling Session Wed Oct 28 2:45pm–4:15pm Workshop 3: Integrating Apheresis, HLA Diagnostics and Clinical Management of the Sensitized Patient HLA antibodies, crossmatching and epletsSolid organ transplantation Talk Thu Oct 29 2:10pm–2:40pm Biopsy-proven ABMR in the Absence of Detectable HLA-DSA Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Antibody Against Epitope 76V+80N Causes Unexpected Positive Crossmatches: A case for listing HLA-c as unacceptable HLA antibodies, crossmatching and eplets Poster Peptide-Dependent Donor-Specific HLA Heterodimer Antibodies Independently Predict Adverse Transplant Outcomes HLA antibodies, crossmatching and eplets |
Mayo Clinic Rochester, MN | |
Academic medical center with campuses in Minnesota, Arizona and Florida. | Poster Long-Read Oxford Nanopore Sequencing Resolves Novel Full-Length HLA-DPB1 Alleles HLA typing, sequencing and genotyping Poster Detection of HLA loss in a Haploidentical Hematopoietic Stem Cell Transplant Recipient by Next Generation Sequencing: A Case Report Chimerism, cell-free DNA and post-transplant monitoringStem cell transplantation and cell therapy Poster Assessment of Chimerism in Allogeneic Hematopoietic Stem Cell Retransplant Recipients by Two Next Generation Sequencing Based Assays Chimerism, cell-free DNA and post-transplant monitoringStem cell transplantation and cell therapy Poster Unmasking False-Positive Anti-HLA reactivity in Luminex SAB Assays Using Adsorption/Elution and Surrogate Flow Cytometry Crossmatch HLA antibodies, crossmatching and eplets Poster Impact of HLA Molecular Mismatch Load on Immune-Mediated outcomes in Heart Transplant Recipients Bridged with Temporary Mechanical Circulatory Support Bioinformatics, AI and risk modelingSolid organ transplantation |
UPMC Pittsburgh, PA | |
Pittsburgh-based academic health system affiliated with the University of Pittsburgh, with hospitals and a large transplant program. | Talk Tue Oct 27 8:15am–9:15am Keynote Address: Transforming Transplantation: Advances in Xenogeneic and Stem Cell Therapies Through Genome Editing Solid organ transplantationStem cell transplantation and cell therapy Talk Tue Oct 27 3:45pm–4:00pm A New Bioinformatics Algorithm to Impute High-Resolution Genotypes from Low-Resolution Molecular Typing Datasets Using a Complete 11-gene Haplotype Reference from NMDP Bioinformatics, AI and risk modelingHLA typing, sequencing and genotyping Talk Thu Oct 29 10:00am–10:15am Poster HLA-DR Molecular Mismatch Stratifies the Risk for Early Acute Cellular Rejection in Lung Transplant Recipients Bioinformatics, AI and risk modelingSolid organ transplantation Poster A Cord Blood Transplant Recipient as a Deceased Organ Donor: Implications of chimerism and sample source for HLA and ABO typing HLA typing, sequencing and genotypingChimerism, cell-free DNA and post-transplant monitoring |
Find buyers in bioinformatics, AI and risk modeling
Tell us what you sell and we’ll find the people at organizations working on bioinformatics, AI and risk modeling most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ASHI 2026 by
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction